How can we begin to measure recovery?

Substance Abuse: Treatment, Prevention, and Policy

Volumn 5, Issue 1, 2010, Pages

  Dodge, Karen ^a,b,c   Krantz, Barbara ^a,b,c   Kenny, Paul J ^d  

^a Hanley Center   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NOVA SOUTHEASTERN UNIVERSITY   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; CONSENSUS; DRUG DEPENDENCE TREATMENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; METHODOLOGY; OUTCOME ASSESSMENT; PARTICIPATORY RESEARCH; PSYCHOLOGICAL ASPECT; THEORETICAL MODEL; UNITED STATES;

COMMUNITY-BASED PARTICIPATORY RESEARCH; CONSENSUS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLORIDA; HUMANS; MALE; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 78649735976     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-5-31     Document Type: Article

References (27)

1. Laudet A. What does recovery mean to you? Lessons from the recovery experience for research and practice. J Subst Abuse Treat 2007, 33:243-256. 10.1016/j.jsat.2007.04.014, 2083562, 17889296.
2. Laudet A, Morgen K, White W. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individual in recovery from drug and alcohol use. Alcohol Treat Quart 2006, 24:33-73.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Washington, DC, 4, Text Rev, American Psychiatric Association.
4. The Betty Ford Institute Consensus Panel What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 2007, 33:221-228. 10.1016/j.jsat.2007.06.001, 17889294, The Betty Ford Institute Consensus Panel.
5. Arndt S, Taylor P. Commentary on "Defining and Measuring Recovery'". J Subst Abuse Treat 2007, 33:275-276.
6. White WL. Addiction recovery: Its definition and conceptual boundaries. J Subst Abuse Treat 2007, 33:229-242. 10.1016/j.jsat.2007.04.015, 17889295.
7. White WL. Recovery Management and Recovery-Oriented Systems of Care: Scientific Rationale and Promising Practices, 2008 , http://www.facesandvoicesofrecovery.org/pdf/White/recovery_monograph_2008.pdf
8. Galanter M. Spirituality and recovery in 12-step programs: An empirical model. J Subst Abuse Treat 2007, 33:265-272. 10.1016/j.jsat.2007.04.016, 17889297.
9. McLellan AT, Chalk, Bartlett. Outcomes, performance, and quality - What's the difference?. J Subst Abuse Treat 2007, 32:331-340. 10.1016/j.jsat.2006.09.004, 17481456.
10. U.S. Substance Abuse and Mental Health Services Administration A report required by Congress on performance partnerships, 2005 Washington, DC, Author, U.S. Substance Abuse and Mental Health Services Administration.
11. McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25:Origins, contributions, and transitions. Am J Addictions 2006, 15:113-124.
12. Kraemer HC, Chmura H, Schultz SK, Arndt S. Biomarkers in Psychiatry: Methodological issues. Am J Geriatric Psychiatry 2002, 12:653-659.
13. Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nature Reviews Drug Discovery 2003, 2:566-580. 10.1038/nrd1130, 12838269.
14. Harris GC, Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends in Neurosci 2006, 29:571-577.
15. DiLeone RJ, Georgescu D, Nestler EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci 2003, 73:759-768. 10.1016/S0024-3205(03)00408-9, 12801597.
16. Boutrel B, De Lecca L. Addiction and arousal: The hypocretin connection. Physiology and Behavior 2008, 93:947-951. 10.1016/j.physbeh.2007.11.022, 18262574.
17. Kovacs GL, Sarnyai Z, Szabo G. Oxytocin and addiction: A review. Pyschoneuroendocrinology 1998, 23:945-962.
18. Buydens-Braunchley L, Braunchley M, Hudson J, Majewska DM. Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts. Psychoneuroendocrinology 2002, 27:83-97. 10.1016/S0306-4530(01)00037-3, 11750771.
19. Frederick SL, Reus VI, Ginsberg D, Hall S, Munoz R, Ellman G. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smoking. Biol Psychiatry 1998, 43:525-530. 10.1016/S0006-3223(97)00423-X, 9547932.
20. Lovallo K. Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiology 2005, 59:195-202.
21. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975, 12:189-198.
22. Brown L, Sherbenou RJ, Johnsen SK. Manual of Test of Nonverbal Intelligence 1997, Austin, TX: PRO-ED, Third.
23. Shipley WC. Shipley Institute of Living Scale 1940, Los Angeles:Western Psychological Services.
24. Butcher JN, Megargee EI. Minnesota Multiphasic Personality Inventory-2 (MMPI-2) 2001, San Antonio, TX: Pearson.
25. Galanter M, Dermatis H, Bunt G, Williams C, Trujillo M, Steinke P. Assessment of spirituality and its relevance to addiction treatment. J Sub Abuse Treat 2007, 33:257-264.
26. Carise D, McLellan AT. Increasing Cultural Sensitivity of the Addiction Severity Index (ASI) 1999, Rockville, MD: Center for Substance Abuse Treatment.
27. Shaffer HJ, LaPlante DA, LaBrie RA, Kidman RC, Donato AN, Stanton MV. Toward a syndrome model of addiction: Multiple expressions, common etiology. Harv Rev Psychiatry 2004, 12:367-374. 10.1080/10673220490905705, 15764471.